Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4584 participants
OBSERVATIONAL
2013-02-22
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Description of Septic Thrombophlebitis on Central Venous Catheter and Midline
NCT05743738
Prone Position Impact in ARDS Patients on the Incidence of Central Venous Catheter Colonization
NCT03405038
The Central Venous Catheter Related Complications in Critically Ill Patients
NCT03841240
Complications and Failure of Centrally Inserted Central Catheters in Cardiac Surgical Patients
NCT07138690
Incidence of Deep Vein Thrombosis on Central Venous Catheters in the Post Operative Period of Carcinologic Surgery
NCT03157245
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Surgical Drains are commonly inserted at the end of many surgical procedures. In contrast to potential benefits, drains are also thought to potentially serve as a conduit of bacteria into the wound and hence may increase the risk of SSI. Patterns of use of drains vary widely across surgical disciplines and individual practices. There are no uniform guidelines and standards are often rather based on tradition than on evidence. The aim of this large prospective study was to examine the association of presence, duration, type, number and location of drains with the risk of SSI in a contemporary and multicentric cohort of general, orthopedic trauma and vascular surgery procedures.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No drainage
Those patients that underwent surgery and no drain was inserted at the end of the procedure
No interventions assigned to this group
Drainage
Those patients that underwent surgery and one or several drains were inserted at the end of the procedure.
Insertion of drainage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Insertion of drainage
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 years or older
* General, orthopedic trauma and vascular procedures
* Surgical antimicrobial prophylaxis
Exclusion Criteria
* Presence of a contraindication for cefuroxime and/or metronidazole
* preexisting antibiotic therapy within 14 days prior to surgery
* cognitive impairment
* combined operations including other than the above specified surgical divisions
* Emergency procedures with planned incision within 2 hours after indicating the procedure.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Edin Mujagic
Edin Mujagic, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Edin Mujagic, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
References
Explore related publications, articles, or registry entries linked to this study.
Weber WP, Mujagic E, Zwahlen M, Bundi M, Hoffmann H, Soysal SD, Kraljevic M, Delko T, von Strauss M, Iselin L, Da Silva RXS, Zeindler J, Rosenthal R, Misteli H, Kindler C, Muller P, Saccilotto R, Lugli AK, Kaufmann M, Gurke L, von Holzen U, Oertli D, Bucheli-Laffer E, Landin J, Widmer AF, Fux CA, Marti WR. Timing of surgical antimicrobial prophylaxis: a phase 3 randomised controlled trial. Lancet Infect Dis. 2017 Jun;17(6):605-614. doi: 10.1016/S1473-3099(17)30176-7. Epub 2017 Apr 3.
Mujagic E, Zwimpfer T, Marti WR, Zwahlen M, Hoffmann H, Kindler C, Fux C, Misteli H, Iselin L, Lugli AK, Nebiker CA, von Holzen U, Vinzens F, von Strauss M, Reck S, Kraljevic M, Widmer AF, Oertli D, Rosenthal R, Weber WP. Evaluating the optimal timing of surgical antimicrobial prophylaxis: study protocol for a randomized controlled trial. Trials. 2014 May 24;15:188. doi: 10.1186/1745-6215-15-188.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ch10Weber
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.